INS and metabolic dysfunction-associated steatotic liver disease: Also, the present study found that the presence of NAFLD was associated with increased risk of severe hypoglycemia by 1.3-fold, a relatively modest association compared with established risk factors such as insulin or sulfonylurea use and CKD.